7th Jun 2022 21:20
Diaceutics PLC - UK testing laboratories company - Announces "significant enhancements" to its DXRX platform in order to improve user experience. Company says customers will now be able to access three new AI-powered tools to ensure medicines get to patients quicker.
"This is an important new release for our customers, allowing a greater level of self service and flexibility when using the DXRX platform," says Scott Gamester, vice president of Data & Platform at Diaceutics.
Current stock price: 107.00 pence
12-month change: down 14%
By Heather Rydings; [email protected]
Copyright 2022 Alliance News Limited. All Rights Reserved.
Related Shares:
Diaceutics